Macmillon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.94 M
- Company Age 36 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
- Satisfied Charges ₹ 4.59 Cr
About Macmillon Pharmaceuticals
Macmillon Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 September 1988 and has a history of 36 years and four months. Its registered office is in Punjab, Punjab.
The Corporate was formerly known as Macmillon Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.94 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan, Naresh Mahajan, Asar Khan, and One other member serve as directors at the Company.
Company Details
- LocationPunjab, Punjab
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231PB1988PTC008661
- Company No.
008661
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Macmillon Pharmaceuticals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sahil Mahajan | Director | 25-Jun-2005 | Current |
Naresh Mahajan | Director | 01-Apr-1996 | Current |
Asar Khan | Whole-Time Director | 20-Dec-2014 | Current |
Satish Kumar | Director | 03-Oct-2017 | Current |
Financial Performance of Macmillon Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Macmillon Pharmaceuticals?
Unlock access to Macmillon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹30.00 M
₹45.90 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 3.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Jul 2011 | Bank Of Baroda | ₹3.00 Cr | Open |
24 Feb 2014 | Bank Of Baroda | ₹3.40 M | Satisfied |
23 Dec 2013 | Bank Of Baroda | ₹3.90 M | Satisfied |
31 May 2000 | Bank Of Baroda | ₹1.78 Cr | Satisfied |
14 Sep 1996 | Bank Of Baroda | ₹2.50 M | Satisfied |
How Many Employees Work at Macmillon Pharmaceuticals?
Unlock and access historical data on people associated with Macmillon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macmillon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macmillon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.